- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BAK
- Stock Information
- Founded
- KNSA 2015
- BAK 1972
- Country
- KNSA United Kingdom
- BAK Brazil
- Employees
- KNSA N/A
- BAK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- KNSA Health Care
- BAK Industrials
- Exchange
- KNSA Nasdaq
- BAK Nasdaq
- Market Cap
- KNSA 2.0B
- BAK 1.6B
- IPO Year
- KNSA 2018
- BAK N/A
- Fundamental
- Price
- KNSA $26.03
- BAK $3.62
- Analyst Decision
- KNSA Strong Buy
- BAK Strong Buy
- Analyst Count
- KNSA 6
- BAK 3
- Target Price
- KNSA $38.00
- BAK $9.75
- AVG Volume (30 Days)
- KNSA 677.6K
- BAK 652.7K
- Earning Date
- KNSA 04-29-2025
- BAK 05-20-2025
- Dividend Yield
- KNSA N/A
- BAK N/A
- EPS Growth
- KNSA N/A
- BAK N/A
- EPS
- KNSA N/A
- BAK N/A
- Revenue
- KNSA $481,166,000.00
- BAK $12,516,128,020.00
- Revenue This Year
- KNSA $37.21
- BAK $18.87
- Revenue Next Year
- KNSA $1.53
- BAK $5.91
- P/E Ratio
- KNSA N/A
- BAK N/A
- Revenue Growth
- KNSA 59.45
- BAK 9.70
- 52 Week Low
- KNSA $17.38
- BAK $2.85
- 52 Week High
- KNSA $28.56
- BAK $7.96
- Technical
- Relative Strength Index (RSI)
- KNSA 63.21
- BAK 48.21
- Support Level
- KNSA $25.97
- BAK $3.53
- Resistance Level
- KNSA $28.56
- BAK $3.99
- Average True Range (ATR)
- KNSA 1.24
- BAK 0.18
- MACD
- KNSA 0.36
- BAK 0.00
- Stochastic Oscillator
- KNSA 71.70
- BAK 22.73
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.